Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Effect of periodontopathogen lipopolysaccharides and proinflammatory cytokines on CD46, CD55, and CD59 gene/protein expression by oral epithelial cells.

Mahtout H, Curt S, Chandad F, Rouabhia M, Grenier D.

FEMS Immunol Med Microbiol. 2011 Aug;62(3):295-303. doi: 10.1111/j.1574-695X.2011.00813.x. Epub 2011 Jun 8.

3.

Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.

Gorter A, Blok VT, Haasnoot WH, Ensink NG, Daha MR, Fleuren GJ.

Lab Invest. 1996 Jun;74(6):1039-49.

PMID:
8667608
4.

Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.

Geis N, Zell S, Rutz R, Li W, Giese T, Mamidi S, Schultz S, Kirschfink M.

Curr Cancer Drug Targets. 2010 Dec;10(8):922-31.

PMID:
20879979
5.

Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.

Spiller OB, Criado-García O, Rodríguez De Córdoba S, Morgan BP.

Clin Exp Immunol. 2000 Aug;121(2):234-41.

6.

Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.

Moutabarrik A, Nakanishi I, Namiki M, Hara T, Matsumoto M, Ishibashi M, Okuyama A, Zaid D, Seya T.

Lymphokine Cytokine Res. 1993 Jun;12(3):167-72.

PMID:
7688580
7.
8.

Complement gene expression is regulated by pro-inflammatory cytokines and the anaphylatoxin C3a in human tenocytes.

Busch C, Girke G, Kohl B, Stoll C, Lemke M, Krasnici S, Ertel W, Silawal S, John T, Schulze-Tanzil G.

Mol Immunol. 2013 Apr;53(4):363-73. doi: 10.1016/j.molimm.2012.09.001. Epub 2012 Oct 13.

PMID:
23070120
9.

Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.

Brasoveanu LI, Altomonte M, Fonsatti E, Colizzi F, Coral S, Nicotra MR, Cattarossi I, Cattelan A, Natali PG, Maio M.

Lab Invest. 1996 Jan;74(1):33-42.

PMID:
8569195
10.

Cytokines affect resistance of human renal tumour cells to complement-mediated injury.

Blok VT, Gelderman KA, Tijsma OH, Daha MR, Gorter A.

Scand J Immunol. 2003 Jun;57(6):591-9.

11.
13.

Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation.

van Beek J, van Meurs M, 't Hart BA, Brok HP, Neal JW, Chatagner A, Harris CL, Omidvar N, Morgan BP, Laman JD, Gasque P.

J Immunol. 2005 Feb 15;174(4):2353-65.

14.
15.

Fusobacterium nucleatum binding to complement regulatory protein CD46 modulates the expression and secretion of cytokines and matrix metalloproteinases by oral epithelial cells.

Mahtout H, Chandad F, Rojo JM, Grenier D.

J Periodontol. 2011 Feb;82(2):311-9. doi: 10.1902/jop.2010.100458. Epub 2010 Sep 15.

PMID:
20843232
16.

Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.

Schmitt CA, Schwaeble W, Wittig BM, Meyer zum Büschenfelde KH, Dippold WG.

Eur J Cancer. 1999 Jan;35(1):117-24.

PMID:
10211099
17.

C-reactive protein upregulates complement-inhibitory factors in endothelial cells.

Li SH, Szmitko PE, Weisel RD, Wang CH, Fedak PW, Li RK, Mickle DA, Verma S.

Circulation. 2004 Feb 24;109(7):833-6. Epub 2004 Feb 16.

PMID:
14967730
18.
19.

Expression and modulation of RPE cell membrane complement regulatory proteins.

Yang P, Tyrrell J, Han I, Jaffe GJ.

Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3473-81. doi: 10.1167/iovs.08-3202. Epub 2009 Jan 24.

PMID:
19168900
20.

Analysis of membrane-bound complement regulatory proteins in prostate cancer.

Loberg RD, Wojno KJ, Day LL, Pienta KJ.

Urology. 2005 Dec;66(6):1321-6.

PMID:
16360477

Supplemental Content

Support Center